Intracoronary autologous bone marrow cell transfer after myocardial infarction: the BOOST-2 randomised placebo-controlled clinical trial-Reference-Cited by-同舟云学术

Intracoronary autologous bone marrow cell transfer after myocardial infarction: the BOOST-2 randomised placebo-controlled clinical trial

Published:2017-04-19 Issue:39 Volume:38 Page:2936-2943
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:

Author:

Wollert Kai C,Meyer Gerd P,Müller-Ehmsen Jochen,Tschöpe Carsten,Bonarjee Vernon,Larsen Alf Inge,May Andreas E,Empen Klaus,Chorianopoulos Emmanuel,Tebbe Ulrich,Waltenberger Johannes,Mahrholdt Heiko,Ritter Benedikta,Pirr Jens,Fischer Dieter,Korf-Klingebiel Mortimer,Arseniev Lubomir,Heuft Hans-Gert,Brinchmann Jan E,Messinger Diethelm,Hertenstein Bernd,Ganser Arnold,Katus Hugo A,Felix Stephan B,Gawaz Meinrad P,Dickstein Kenneth,Schultheiss Heinz-Peter,Ladage Dennis,Greulich Simon,Bauersachs Johann

Funder

German Research Foundation

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartj/article-pdf/38/39/2936/21193586/ehx188.pdf

Reference23 articles.

1. Reperfusion strategies in acute coronary syndromes;Circ Res,2014

2. Risk of heart failure complication during hospitalization for acute myocardial infarction in a contemporary population: insights from the National Cardiovascular Data ACTION Registry;Circ Heart Fail,2012

3. Impact of left ventricular function in relation to procedural outcomes following percutaneous coronary intervention: insights from the British Cardiovascular Intervention Society;on behalf of the British Cardiovascular Intervention Society and the National Institute for Cardiovascular Outcomes Research;Eur Heart J,2014